Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Juxtaposing zero-based with monthly budgeting highlights where each excels, aiding you in selecting a method that fits your life and income cadence.
28,655 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Jupiter, the Solana-based decentralized exchange, expands into tokenized IP by listing onchain Pokémon cards. The mov...
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
Omega Advisors’ three-name portfolio mix highlights a diversified stance on AI infrastructure, consumer finance, and ...
When a major holding shows a sharp fall after earnings, investors scramble for answers. This guide breaks down the re...
AI stocks are on fire, yet one AI stock has fallen 24.27% from its recent high. This guide explains why the rally has...
With SpaceX poised to hit the public markets, a wave of megadeals led by Elon Musk looms. Analysts warn the IPO could...
Nvidia delivered a record-breaking quarter, but a steely market mood leaves its stock rangebound. A steward partners ...
Amazon's MGM-backed film Project Hail Mary roared out of the gate with an $80.5 million opening in the U.S. and Canad...
JPMorgan CEO Jamie Dimon argues the United States is drifting toward Europe’s slower defense model, calling for priva...
As markets swing in May 2026, a fresh analysis shows how cutting costs can undermine long-term investing. Here are ei...
Memory-chip giants Micron and SK Hynix push into the $1 trillion market-cap club, signaling renewed confidence in AI-...